Search hospitals > New York > Rochester
Rochester Clinical Research, Inc
Claim this profileRochester, New York 14609
Global Leader in Migraine
Global Leader in Flu
Conducts research for Coronavirus
Conducts research for Obesity
Conducts research for Osteoarthritis
245 reported clinical trials
8 medical researchers
Summary
Rochester Clinical Research, Inc is a medical facility located in Rochester, New York. This center is recognized for care of Migraine, Flu, Coronavirus, Obesity, Osteoarthritis and other specialties. Rochester Clinical Research, Inc is involved with conducting 245 clinical trials across 172 conditions. There are 8 research doctors associated with this hospital, such as Matthew G Davis, MD, Patricia Lee, MD, Matthew Gilruth Davis, and Patrick Michael Connors.Area of expertise
1Migraine
Global Leader2Flu
Global Leaderestrogen
ER
Top PIs
Matthew G Davis, MDGSK Investigational Site1 year of reported clinical research
Studies Respiratory Syncytial Virus
Studies Chikungunya Fever
18 reported clinical trials
27 drugs studied
Patricia Lee, MDCenter for Clinical Studies3 years of reported clinical research
Studies Atopic Dermatitis
Studies Eczema
6 reported clinical trials
7 drugs studied
Matthew Gilruth DavisRochester Clinical Research, Inc.4 years of reported clinical research
Studies Obesity
Studies Migraine
5 reported clinical trials
4 drugs studied
Patrick Michael ConnorsRochester Clinical Research, Inc.1 year of reported clinical research
Studies Obesity
3 reported clinical trials
4 drugs studied
Clinical Trials running at Rochester Clinical Research, Inc
Obesity
Migraine
Atopic Dermatitis
Coronavirus
Psoriasis
Ulcerative Colitis
Flu
Eczema
Cardiovascular Disease
Primary Hyperoxaluria
Retatrutide
for Obesity and Cardiovascular Disease
This trial is testing a medication called retatrutide in people who have both obesity and heart disease. The study will last over two years to see if the medication is safe and effective.
Recruiting1 award Phase 33 criteria
Tirzepatide
for Obesity
This trial is testing tirzepatide, a medication that helps control blood sugar and reduce appetite, to see if it can lower health problems and death rates in adults who are very overweight. Tirzepatide was developed by Eli Lilly to improve blood sugar control in adults with type 2 diabetes.
Recruiting1 award Phase 39 criteria
LY3305677
for Obesity
The purpose of this Phase-2 chronic weight management master protocol (CWMM) is to create a framework to evaluate the safety and efficacy of various investigational interventions for chronic weight management with intervention-specific appendices (ISAs). The ISAs may start independently of other ISAs as interventions become available for clinical testing.
Recruiting0 awards Phase 23 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Rochester Clinical Research, Inc?
Rochester Clinical Research, Inc is a medical facility located in Rochester, New York. This center is recognized for care of Migraine, Flu, Coronavirus, Obesity, Osteoarthritis and other specialties. Rochester Clinical Research, Inc is involved with conducting 245 clinical trials across 172 conditions. There are 8 research doctors associated with this hospital, such as Matthew G Davis, MD, Patricia Lee, MD, Matthew Gilruth Davis, and Patrick Michael Connors.